Raia Drogasil S.A.
RADLY
$4.48
$0.010.22%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.42B | 7.16B | 7.10B | 7.22B | 7.30B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.42B | 7.16B | 7.10B | 7.22B | 7.30B |
| Cost of Revenue | 5.25B | 5.05B | 5.00B | 5.08B | 5.12B |
| Gross Profit | 2.18B | 2.10B | 2.10B | 2.15B | 2.18B |
| SG&A Expenses | 1.74B | 1.69B | 1.69B | 1.71B | 1.73B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -239.50K | -8.16M | -6.87M | -233.30K | -21.48M |
| Total Operating Expenses | 6.99B | 6.73B | 6.68B | 6.79B | 6.83B |
| Operating Income | 432.78M | 421.25M | 420.42M | 439.15M | 466.73M |
| Income Before Tax | 252.52M | 232.03M | 241.26M | 263.59M | 275.52M |
| Income Tax Expenses | 12.41M | 15.54M | 29.28M | 40.77M | 56.07M |
| Earnings from Continuing Operations | 240.11 | 216.49 | 211.98 | 222.82 | 219.45 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -3.16M | -2.49M | -1.30M | -2.22M | -5.72M |
| Net Income | 236.95M | 214.00M | 210.68M | 220.60M | 213.73M |
| EBIT | 432.78M | 421.25M | 420.42M | 439.15M | 466.73M |
| EBITDA | 566.44M | 552.80M | 549.38M | 570.47M | 600.33M |
| EPS Basic | 0.14 | 0.13 | 0.11 | 0.12 | 0.11 |
| Normalized Basic EPS | 0.09 | 0.09 | 0.08 | 0.09 | 0.09 |
| EPS Diluted | 0.14 | 0.13 | 0.11 | 0.12 | 0.11 |
| Normalized Diluted EPS | 0.09 | 0.09 | 0.08 | 0.09 | 0.09 |
| Average Basic Shares Outstanding | 6.59B | 6.59B | 7.81B | 7.82B | 7.88B |
| Average Diluted Shares Outstanding | 6.62B | 6.62B | 7.83B | 7.84B | 7.91B |
| Dividend Per Share | 0.04 | 0.05 | 0.03 | 0.02 | 0.07 |
| Payout Ratio | 40.00% | 44.38% | 40.88% | 39.05% | 44.02% |